AI-generated summary
The authors studied 16 people with type II diabetes and lower-limb ulcers, comparing eight who received red laser therapy (632.8 nm) with eight controls over 30 days. The authors report that wound size decreased more in the treated group and that pain improved, and they describe the treatment as efficient and viable. The small sample size limits how far these findings can be generalized.
- Participants
- 16
- Who or what was studied
- Sixteen adults with type II diabetes and ulcers on the lower limbs, divided into a treatment group of eight and a control group of eight.
- Wavelengths
- 632 nm
- Limits stated in the abstract
- The abstract reports only 16 participants split into two groups of eight, and it does not describe randomization or blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scielo.br.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 4J/cm2
- Power
- 30 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.